Colon Adenocarcinoma — Trials

Colon Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02912559	Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair	active not recruiting	Phase 3	712	National Cancer Institute (NCI)NIH	3	Aug 4, 2026	clinicaltrials
NCT05710406	Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer	active not recruiting	Phase 2 / Phase 3	1	Alliance for Clinical Trials in OncologyOTHER	1	Jul 2, 2026